Journal Mobile Options
Table of Contents
Vol. 113, No. 1-4, 2006
Issue release date: March 2006

Regulation of growth and metabolism by imprinted genes

Smith F.M. · Garfield A.S. · Ward A.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

A small sub-set of mammalian genes are subject to regulation by genomic imprinting such that only one parental allele is active in at least some sites of expression. Imprinted genes have diverse functions, notably including the regulation of growth. Much attention has been devoted to the insulin-like growth factor signalling pathway that has a major influence on fetal size and contains two components encoded by the oppositely imprinted genes, Igf2 (a growth promoting factor expressed from the paternal allele) and Igf2r (a growth inhibitory factor expressed from the maternal allele). These genes fit the parent-offspring conflict hypothesis for the evolution of genomic imprinting. Accumulated evidence indicates that at least one other fetal growth pathway exists that has also fallen under the influence of imprinting. It is clear that not all components of growth regulatory pathways are encoded by imprinted genes and instead it may be that within a pathway the influence of a single gene by each of the parental genomes may be sufficient for parent-offspring conflict to be enacted. A number of imprinted genes have been found to influence energy homeostasis and some, including Igf2 and Grb10, may coordinate growth with glucose-regulated metabolism. Since perturbation of fetal growth can be correlated with metabolic disorders in adulthood these imprinted genes are considered as candidates for involvement in this phenomenon of fetal programming.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Accili D, Arden KC: FoxOs at the crossroads of cellular metabolism, differentiation and transformation. Cell 117:421–426 (2004).
  2. Arnaud P, Monk D, Hitchins M, Gordon E, Dean W, Beechey CV, Peters J, Craigen W, Preece M, Stanier P, Moore GE, Kelsey G: Conserved methylation imprints in the human and mouse GRB10 genes with divergent allelic expression suggests differential reading of the same mark. Hum Mol Genet 12:1005–1019 (2003).
  3. Arney KL: H19 and Igf2–enhancing the confusion? Trends Genet 19:17–23 (2003).
  4. Asano M, Furukawa K, Kido M, Matsumoto S, Umesaki Y, Kochibe N, Iwakura Y: Growth retardation and early death of beta-14-galactosyltransferase knockout mice with augmented prolifera tion and abnormal differentiation of epithelial cells. EMBO J 16:1850–1857 (1997).
  5. Baker J, Liu JP, Robertson EJ, Efstratiadis A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73–82 (1993).
  6. Bennett WR, Crew TE, Slack JMW, Ward A: Structural-proliferative units and organ growth: effects of insulin-like growth factor 2 on growth of colon and skin. Development 130:1079–1088 (2003).
  7. Blagitko N, Mergenthaler S, Schulz U, Wollmann HA, Craigen W, Eggermann T, Ropers HH, Kalscheuer VM: Human GRB10 is imprinted and expressed from the paternal and maternal allele in a highly tissue- and isoform-specific fashion. Hum Mol Genet 9:1587–1595 (2000).
  8. Brogiolo W, Stocker H, Ikeya T, Rintelen F, Fernandez R, Hafen E: An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr Biol 11:213–221 (2001).
  9. Brown KW,Villar AJ, Bickmore W, Clayton-Smith J, Catchpoole D, Maher ER, Reik W: Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. Hum Mol Genet 5:2027–2032 (1996).
  10. Burns JL, Hassan AB: Cell survival and proliferation are modified by insulin-like growth factor 2 between days 9 and 10 of mouse gestation. Development 128:3819–3830 (2001).
  11. Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TM, Yeger H, Lockwood GA, Rosenblum ND, Filmus J: Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel Syndrome. J Cell Biol 146:255–264 (1999).
  12. Caspary T, Cleary MA, Perlman EJ, Zhang P, Elledge SJ, Tilghman SM: Oppositely imprinted genes p57(Kip2) and Igf2 interact in a mouse model for Beckwith-Wiedemann syndrome. Genes Dev 13: 3115–3124 (1999).
  13. Cattanach BM, Beechey CV, Raspberry C, Jones J, Papworth D: Time of initiation and sites of action of the mouse chromosome 11 imprinting effects. Genet Res 68:35–44 (1996).
  14. Charalambous M, Smith FM, Bennett WR, Crew TE, Mackenzie F, Ward A: Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2 independent mechanism. Proc Natl Acad Sci USA 100:8292–8297 (2003).
  15. Chen M, Gavrilova O, Liu J, Xie T, Deng C, Nguyen AT, Nackers LM, Lorenzo J, Shen L, Weinstein LS: Alternative Gnas gene products have opposite effects on glucose and lipid metabolism. Proc Natl Acad Sci USA 102:7386–7391 (2005).
  16. Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Sclessinger D, Pilia G, Efstratiadis A: Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signalling. Dev Biol 243:185–206 (2002).
  17. Clairmont KB, Czech MP: Chicken and Xenopus mannose 6-phosphate receptors fail to bind insulin-like growth factor II. J Biol Chem 264:16390–16392 (1989).
  18. Constância M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W: Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417:945–948 (2002).
  19. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR, Feinberg AP: Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299:1753–1755 (2003).
  20. Curley JP, Barton S, Surani A, Keverne EB: Coadaptation in mother and infant regulated by a paternally expressed imprinted gene. Proc Biol Sci 271:1303–1309 (2004).

    External Resources

  21. Da Costa THM, Williamson DH, Ward A, Bates P, Fisher R, Richardson L, Hill D, Robinson ICAF, Graham CF: High plasma insulin-like growth factor II (IGF-II) levels and low lipid content in transgenic mice: measurements of lipid metabolism. J Endocrinol 143:433–439 (1994).
  22. Dao D, Frank D, Qian N, O’Keefe D, Vosatka RJ, Walsh CP, Tycko B: IMPT1 an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Hum Mol Genet 7:597–608 (1998).
  23. Davis AC, Wims M, Spotts GD, Hann SR, Bradley A: A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev 7:671–682 (1993).
  24. DeChiara TM, Robertson EJ, Efstratiadis A: A growth deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78–80 (1990).
  25. DeChiara TM, Efstratiadis A, Robertson EJ: Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849–859 (1991).
  26. Efstratiadis A: Genetics of mouse growth. Int J Dev Biol 42:955–976 (1998).
  27. Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman SM, Efstratiadis A: Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev 11:3128–3142 (1997).
  28. Eggermann K, Wollmann HA, Tomiuk J, Ranke MB, Kaiser P, Eggermann T: Screening for mutations in the promoter and the coding region of the IGFBP1 and IGFBP3 genes in Silver-Russell syndrome patients. Hum Hered 49:123–128 (1999).
  29. Font de Mora J, Esteban LM, Burks DJ, Nunez A, Garces C, Garcia-Barrado MJ, Iglesias-Osma MC, Moratinos J, Ward JM, Santos F: Ras-GRF1 signalling is required for normal beta-cell development and glucose homeostasis. EMBO J 22:3039–3049 (2003).
  30. Frank D, Fortino W, Clark L, Musalo R, Wang W, Saxena A, Li CM, Reik W, Ludwig T, Tycko B: Placental overgrowth in mice lacking the imprinted gene Ipl. Proc Natl Acad Sci USA 99:7490–7495 (2002).
  31. Grandjean V, Smith J, Schofield PN, Ferguson-Smith AC: Increased IGF-II protein affects p57kip2 expression in vivo and in vitro: implications for Beckwith-Wiedemann syndrome. Proc Natl Acad Sci USA 97:5279–5284 (2000).
  32. Guillemot F, Nagy A, Auerbach A, Rossant J, Joyner AL: Essential role of Mash2 in extraembryonic development. Nature 371:333–336 (1994).
  33. Haig D, Westoby M: Parent-specific gene expression and the triploid endosperm. Am Nat 134:147–155 (1989).

    External Resources

  34. Hannula K, Lipsanen-Nyman M, Kontiokari T, Kere J: A narrow segment of maternal uniparental disomy of chromosome 7q31→qter in Silver-Russell syndrome delimits a candidate gene region. Am J Hum Genet 68:247–253 (2001).
  35. Hansen TV, Hammer NA, Nielsen J, Madsen M, Dalbaeck C, Wewer UM, Christiansen J, Nielsen FC: Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol Cell Biol 24:4448–4464 (2004).
  36. Hoki Y, Araki R, Fujimori A, Ohhata T, Koseki H, Fukumura R, Nakamura M, Takahashi H, Noda Y, Kito S, Abe M: Growth retardation and skin abnormalities of the Recql4-deficient mouse. Hum Mol Genet 12:2293–2299 (2003).
  37. Holmes R, Williamson C, Peters J, Denny P, Wells C: A comprehensive transcript map of the mouse Gnas imprinted complex. Genome Res 13:1410–1415 (2003).
  38. Holt LJ, Siddle K: Grb10 and Grb14: enigmatic regulators of insulin action – and more? Biochem J 388:393–406 (2005).
  39. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, Le Bouc Y: IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421:182–187 (2003).
  40. Hosaka T, Biggs WH 3rd, Tieu D, Boyer AD, Varki NM, Cavenee WK, Arden KC: Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci USA 101:2975–2980 (2004).
  41. Huber R, Hansen RS, Strazzullo M, Pengue G, Mazzarella R, D’Urso M, Schlessinger D, Pilia G, Gartler SM, D’Esposito M: DNA methylation in transcriptional repression of two differentially expressed X-linked genes GPC3 and SYBL1. Proc Natl Acad Sci USA 96:616–621 (1999).
  42. Ide Y, Tsuchimoto D, Tominaga Y, Nakashima M, Watanabe T, Sakumi K, Ohno M, Nakabeppu Y: Growth retardation and dyslymphopoiesis accompanied by G2/M arrest in APEX2-null mice. Blood 104:4097–4103 (2004).
  43. Itier JM, Tremp GL, Leonard JF, Multon MC, Ret G, Schweighoffer F, Tocque B, Bluet-Pajot MT, Cormier V, Dautry F: Imprinted gene in postnatal growth role. Nature 393:125–126 (1998).
  44. Johnston LA, Prober DA, Edgar BA, Eisenman RN, Gallant P: Drosophila myc regulates cellular growth during development. Cell 98:779–790 (1999).
  45. Jones BK, Levorse J, Tilghman SM: Deletion of a nuclease-sensitive region between the Igf2 and H19 genes leads to Igf2 misregulation and increased adiposity. Hum Mol Genet 10:807–814 (2001).
  46. Joyce CA, Sharp A, Walker JM, Bullman H, Temple IK: Duplication of 7p12.1→p13 including GRB10 and IGFBP1 in a mother and daughter with features of Silver-Russell syndrome. Hum Genet 105:273–280 (1999).
  47. Junger MA, Rintelen F, Stocker H, Wasserman JD, Vegh M, Radimerski T, Greenberg ME, Hafen E: The Drosophila forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J Biol 2:20 (2003).
  48. Kanayama N, Takahashi K, Matsuura T, Sugimura M, Kobayashi T, Moniwa N, Tomita M, Nakayama K: Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod 8:1129–1135 (2002).
  49. Killian JK, Byrd JC, Jirtle JV, Munday BL, Stoskopf MK, MacDonald RG, Jirtle RL: M6P/IGF2R imprinting evolution in mammals. Mol Cell 5:707–716 (2000).
  50. Kobayashi S, Wagatsuma H, Ono R, Ichikawa H, Yamazaki M, Tashiro H, Aisaka K, Miyoshi N, Kohda T, Ogura A, et al: Mouse Peg9/Dlk1 and human PEG9/DLK1 are paternally expressed imprinted genes closely located to the maternally expressed imprinted genes: mouse Meg3/Gtl2 and human MEG3. Genes Cells 5:1029–1037 (2000).
  51. Lau MMH, Stewart CEH, Liu Z, Bhatt H, Rotwein P, Stewart CL: Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 8:2953–2963 (1994).
  52. Laustsen PG, Michael MD, Crute BE, Cohen SE, Ueki K, Kulkarni RN, Keller SR, Lienhard GE, Kahn CR: Lipoatrophic diabetes in Irs1(-/-)/ Irs3(-/-) double knockout mice. Genes Dev 16:3213–3222 (2002).
  53. Lee K, Villena JA, Moon YS, Kim KH, Lee S, Kang C, Sul HS: Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest 111:453–461 (2003).
  54. Lefebvre L, Viville S, Barton SC, Ishino F, Keverne EB, Surani MA: Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nat Genet 20:163–169 (1998).
  55. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM: Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375:34–39 (1995).
  56. Lin SC, Skapek SX, Lee EY: Genes in the RB pathway and their knockout in mice. Semin Cancer Biol 7:279–289 (1996).
  57. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59–72 (1993).
  58. Liu J, Nealon JG, Weinstein LS: Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB. Hum Mol Genet 14:95–102 (2005).
  59. Louvi A, Accili D, Efstratiadis A: Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189:33–48 (1997).
  60. Ludwig T, Le Borgne R, Hoflack B: Roles for mannose-6-phosphate receptors in lysosomal enzyme sorting IGF-II binding and clathrin-coat assembly. Trends Cell Biol 5:202–206 (1995).
  61. Ludwig T, Eggenschwiler J, Fisher P, D’Ercole AJ, Davenport ML, Efstratiadis A: Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 177:517–535 (1996).
  62. Luoh SW, Bain PA, Polakiewicz RD, Goodheart ML, Gardner H, Jaenisch R, Page DC: Zfx mutation results in small animal size and reduced germ cell number in male and female mice. Development 124:2275–2284 (1997).
  63. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A: Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141–162 (2001).
  64. Ma D, Shield JP, Dean W, Leclerc I, Knauf C, Burcelin RR, Rutter GA, Kelsey G: Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus TNDM. J Clin Invest 114:339–348 (2004).
  65. Maher ER, Reik W: Beckwith-Wiedemann syndrome: imprinting in clusters revisited. J Clin Invest 105:247–252 (2000).
  66. Mann MR, Bartolomei MS: Towards a molecular understanding of Prader-Willi and Angelman syndromes. Hum Mol Genet 8:1867–1873 (1999).
  67. McCann JA, Zheng H, Islam A, Goodyer CG, Polychronakos C: Evidence against GRB10 as the gene responsible for Silver-Russell syndrome. Biochem Biophys Res Commun 286:943–948 (2001).
  68. McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGFbeta superfamily member. Nature 387:83–90 (1997).
  69. Miyoshi N, Kuroiwa Y, Kohda T, Shitara H, Yonekawa H, Kawabe T, Hasegawa H, Barton SC, Surani MA, Kaneko-Ishino T, Ishino F: Identification of the Meg1/Grb10 imprinted gene on mouse proximal chromosome 11, a candidate for the Silver-Russell syndrome gene. Proc Natl Acad Sci USA 95:1102–1107 (1998).
  70. Mizuno Y, Sotomaru Y, Katsuzawa Y, Kono T, Meguro M, Oshimura M, Kawai J, Tomaru Y, Kiyosawa H, Nikaido I, Amanuma H, Hayashizaki Y, Okazaki Y: Asb4, Ata3 and Dcn are novel imprinted genes identified by high-throughput screening using RIKEN cDNA microarray. Biochem Biophys Res Commun 290:1499–1505 (2002).
  71. Monk D, Wakeling EL, Proud V, Hitchins M, Abu-Amero SN, Stanier P, Preece MA, Moore GE: Duplication of 7p11.2→p13 including GRB10 in Silver-Russell syndrome. Am J Hum Genet 66:36–46 (2000).
  72. Moon YS, Smas CM, Lee K, Villena JA, Kim K-H, Yun EJ, Sul HS: Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol 22:5585–5592 (2002).
  73. Moore T, Haig D: Genomic imprinting in mammalian development: a parental tug-of-war. Trends Genet 7:45–49 (1991).
  74. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K: Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 85:707–720 (1996).
  75. Nijhout HF: The control of growth. Development 130:5863–5867 (2003).
  76. Ohta T, Gray TA, Rogan PK, Buiting K, Gabriel JM, Saitoh S, Muralidhar B, Bilienska B, Krajewska-Walasek M, Driscoll DJ, Horsthemke B, Butler MG, Nicholls RD: Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet 64:397–413 (1999).
  77. Paine-Saunders S, Viviano BL, Zupicich J, Skarnes WC, Saunders S: Glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development. Dev Biol 225:179–187 (2000).
  78. Pant V, Mariano P, Kanduri C, Mattsson A, Lobanenkov V, Heuchel R, Ohlsson R: The nucleotides responsible for the direct physical contact between the chromatin insulator protein CTCF and the H19 imprinting control region manifest parent of origin-specific long-distance insulation and methylation-free domains. Genes Dev 17:586–590 (2003).
  79. Pant V, Kurukuti S, Pugacheva E, Shamsuddin S, Mariano P, Renkawitz R, Klenova E, Lobanenkov V, Ohlsson R: Mutation of a single CTCF target site within the H19 imprinting control region leads to loss of Igf2 imprinting and complex patterns of de novo methylation upon maternal inheritance. Mol Cell Biol 24:3497–3504 (2004).
  80. Peng X-D, Xu P-Z, Chen M-L, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N: Dwarfism impaired skin development, skeletal muscle atrophy, delayed bone development and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17:1352–1365 (2003).
  81. Pilia G, Hughes-Benzie RM, MacKenzie A, Bayban P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D: Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 12:241–247 (1996).
  82. Plagge A, Gordon E, Dean W, Boiani R, Cinti S, Peters J, Kelsey G: The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding. Nat Genet 36:818–826 (2004).
  83. Prawitt D, Enklaar T, Gartner-Rupprecht B, Spangenberg C, Oswald M, Lausch E, Schmidtke P, Reutzel D, Fees S, Lucito R, Korzon M, Brozek I, Limon J, Housman DE, Pelletier J, Zabel B: Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms’ tumor. Proc Natl Acad Sci USA 102:4085–4090 (2005).
  84. Preece MA: The genetics of the Silver-Russell syndrome. Rev Endocr Metab Disord 3:369–379 (2002).
  85. Reik W, Brown KW, Schneid H, Le Bouc Y, Bickmore W, Maher ER: Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum Mol Genet 4:2379–2385 (1995).
  86. Reik W, Constância M, Fowden A, Anderson N, Dean W, Ferguson-Smith A, Tycko B, Sibley C: Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J Physiol 547:35–44 (2003).
  87. Ripoche M-A, Kress C, Poirier F, Dandolo L: Deletion of the H19 transcriptional unit reveals the existence of a putative imprinting control element. Genes Dev 11:1596–1604 (1997).
  88. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, Neely K, Hintz R: Altered body composition and increased frequency of diverse malignancies in IGF-II transgenic mice. J Biol Chem 269:13779–13784 (1994).
  89. Rossant J, Cross JC: Placental development: lessons from mouse mutants. Nat Rev Genet 2:538–548 (2001).
  90. Salas M, John R, Saxena A, Barton S, Frank D, Fitzpatrick G, Higgins MJ, Tycko B: Placental growth retardation due to loss of imprinting of Phlda2. Mech Dev 121:1199–1210 (2004).
  91. Schoor M, Schuster-Gossler K, Roopenian D, Gossler A: Skeletal dysplasias growth retardation reduced postnatal survival and impaired fertility in mice lacking the SNF2/SWI2 family member ETL1. Mech Dev 85:73–83 (1999).
  92. Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, Kozma SC: Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 17:6649–6659 (1998).
  93. Shindo T, Kurihara H, Kuno K, Yokoyama H, Wada T, Kurihara Y, Imai T, Wang Y, Ogata M, Nishimatsu H, Moriyama N, Oh-hashi Y, Morita H, Ishikawa T, Nagai R, Yazaki Y, Matsushima K: ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth fertility and organ morphology and function. J Clin Invest 105:1345–1352 (2000).
  94. Shiura H, Miyoshi N, Konishi A, Wakisaka-Saito N, Suzuki R, Muguruma K, Kohda T, Wakana S, Yokoyama M, Ishino F, Kaneko-Ishino T: Meg1/Grb10 overexpression causes postnatal growth retardation and insulin resistance via negative modulation of the IGF1R and IR cascades. Biochem Biophys Res Commun 329:909–916 (2005).
  95. Sibley CP, Coan PM, Ferguson-Smith AC, Dean W, Hughes J, Smith P, Reik W, Burton GJ, Fowden AL, Constância M: Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci USA 101:8204–8208 (2004).
  96. Smith FM: An investigation of mouse Grb10, an imprinted gene that links fetal growth and insulin-regulated metabolism. University of Bath PhD thesis, Bath (2004).
  97. Song HH, Shi W, Filmus J: OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. J Biol Chem 272:7574–7577 (1997).
  98. Song HH, Shi W, Xiang YY, Filmus J: The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem 280:2116–2125 (2005).
  99. Stocker H, Hafen E: Genetic control of cell size. Curr Opin Genet Dev 10:529–535 (2000).
  100. Sun F-L, Dean WL, Kelsey G, Allen ND, Reik W: Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 389:809–815 (1997).
  101. Takahashi K, Nakayama K: Mice lacking a CDK inhibitor p57Kip2 exhibit skeletal abnormalities and growth retardation. J Biochem (Tokyo) 127:73–83 (2000).
  102. Takahashi K, Kobayashi T, Kanayama N: p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts. Mol Hum Reprod 6:1019–1025 (2000).
  103. Tanaka M, Gertsenstein M, Rossant J, Nagy A: Mash2 acts cell autonomously in mouse spongiotrophoblast development. Dev Biol 190:55–65 (1997).
  104. Thorvaldsen JL, Duran KL, Bartolomei MS: Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev 12:3693–3702 (1998).
  105. Thorvaldsen JL, Mann MR, Nwoko O, Duran KL, Bartolomei MS: Analysis of sequence upstream of the endogenous H19 gene reveals elements both essential and dispensable for imprinting. Mol Cell Biol 22:2450–2462 (2002).
  106. Trumpp A, Refaeli Y, Oskarsson T, Gasser S, Murphy M, Martin GR, Bishop JM: c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414:768–773 (2001).
  107. Walter J, Paulsen M: Imprinting and disease. Semin Cell Dev Biol 14:101–110 (2003).
  108. Wang ZQ, Fung MR, Barlow DP, Wagner EF: Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372:464–467 (1994).
  109. Ward A: Beckwith-Wiedemann syndrome and Wilms’ tumour. Mol Hum Reprod 3:157–168 (1997).
  110. Waterland RA, Jirtle RL: Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23:5293–5300 (2003).
  111. Waterland RA, Jirtle RL: Early nutrition epigenetic changes at transposons and imprinted genes and enhanced susceptibility to adult chronic diseases. Nutrition 20:63–68 (2004).
  112. Yan Y, Frisen J, Lee M-H, Massague J, Barbacid M: Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 11:973–983 (1997).
  113. Yu S, Yu D, Lee E, Eckhaus M, Lee R, Corria Z, Accili D, Westphal H, Weinstein LS: Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the Gsalpha gene. Proc Natl Acad Sci USA 95:8715–8720 (1998).
  114. Yu S, Gavrilova O, Chen H, Lee R, Liu J, Pacak K, Parlow AF, Quon MJ, Reitman ML, Weinstein LS: Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism. J Clin Invest 105:615–623 (2000).
  115. Yu S, Castle A, Chen M, Lee R, Takeda K, Weinstein LS: Increased insulin sensitivity in Gsalpha knockout mice. J Biol Chem 276:19994–19998 (2001).
  116. Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC, Silverman A, Harper JW, DePinho RA, Elledge SJ: Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151–158 (1997).
  117. Zwart R, Verhaagh S, Buitelaar M, Popp-Snijders C, Barlow DP: Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice. Mol Cell Biol 21:4188–4196 (2001).


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50